These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28769812)

  • 1. Systemic Hepatic-Damage Index for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection.
    Gao XH; Zhang SS; Chen H; Wang YH; Yuan CH; Wang FB
    Front Physiol; 2017; 8():480. PubMed ID: 28769812
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.
    Hu B; Yang XR; Xu Y; Sun YF; Sun C; Guo W; Zhang X; Wang WM; Qiu SJ; Zhou J; Fan J
    Clin Cancer Res; 2014 Dec; 20(23):6212-22. PubMed ID: 25271081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation.
    Xin Y; Yang Y; Liu N; Chen Y; Wang Y; Zhang X; Li X; Zhou X
    J Gastrointest Oncol; 2021 Apr; 12(2):735-750. PubMed ID: 34012662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a): a promising prognostic biomarker in patients with hepatocellular carcinoma after curative resection.
    Gao XH; Zhang SS; Chen H; Wang K; Xie W; Wang FB
    Onco Targets Ther; 2018; 11():5917-5924. PubMed ID: 30271176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments.
    Zhao LY; Yang DD; Ma XK; Liu MM; Wu DH; Zhang XP; Ruan DY; Lin JX; Wen JY; Chen J; Lin Q; Dong M; Qi JJ; Hu PS; Zeng ZL; Chen ZH; Wu XY
    J Cancer; 2019; 10(10):2299-2311. PubMed ID: 31258733
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection.
    Wang BL; Tian L; Gao XH; Ma XL; Wu J; Zhang CY; Zhou Y; Guo W; Yang XR
    Clin Chem Lab Med; 2016 Dec; 54(12):1963-1969. PubMed ID: 27010778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection.
    Diao P; Wu Y; Li J; Zhang W; Huang R; Zhou C; Wang Y; Cheng J
    J Transl Med; 2018 Dec; 16(1):365. PubMed ID: 30563540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
    Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
    Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Preoperative Gamma-Glutamyltransferase to Alkaline Phosphatase Ratio in Hepatocellular Carcinoma Patients with Curative Liver Resection: A Retrospective Cohort Study.
    Ouyang G; Pan G; Wu Y; Liu Q; Lu W; Chen X
    Cancer Manag Res; 2020; 12():8721-8732. PubMed ID: 33061570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new laboratory-based algorithm to predict microvascular invasion and survival in patients with hepatocellular carcinoma.
    Zhu Y; Xu D; Zhang Z; Dong J; Zhou Y; Zhang WW; Hong L; Zhu WW
    Int J Surg; 2018 Sep; 57():45-53. PubMed ID: 30075291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic nutritional index is superior as a predictor of prognosis among various inflammation-based prognostic scores in patients with hepatocellular carcinoma after curative resection.
    Imai D; Maeda T; Shimokawa M; Wang H; Yoshiya S; Takeishi K; Itoh S; Harada N; Ikegami T; Yoshizumi T; Mori M
    Hepatol Res; 2020 Jan; 50(1):101-109. PubMed ID: 31692173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After Surgery.
    He W; Peng B; Tang Y; Yang J; Zheng Y; Qiu J; Zou R; Shen J; Li B; Yuan Y
    Clin Gastroenterol Hepatol; 2018 May; 16(5):756-764.e10. PubMed ID: 29246702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of albumin-lymphocyte-platelet-C-reactive protein index as a prognostic indicator of hepatocellular carcinoma after resection: Associated with nuclear factor erythroid 2-related factor 2.
    Iseda N; Itoh S; Toshida K; Nakayama Y; Ishikawa T; Tsutsui Y; Izumi T; Bekki Y; Yoshiya S; Toshima T; Yoshizumi T
    Hepatol Res; 2024 Jan; 54(1):91-102. PubMed ID: 37632704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.
    Cai BB; Shi KQ; Li P; Chen BC; Shi L; Johnson PJ; Lai P; Toyoda H; Zhou MT
    Clin Chim Acta; 2018 Oct; 485():187-194. PubMed ID: 29908940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum IgG4:IgG Ratio Predicts Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.
    Wu J; Ma XL; Tian L; Zhang CY; Wang BL; Hu YY; Gao XH; Zhou Y; Shen MN; Peng YF; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    J Cancer; 2017; 8(8):1338-1346. PubMed ID: 28638447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.